Andros Pharmaceuticals Co (ROCO:6917) Net Margin % : -12,754.52% (As of Dec. 2023)

View and export this data going back to 2023. Start your Free Trial

What is Andros Pharmaceuticals Co Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. Andros Pharmaceuticals Co's Net Income for the six months ended in Dec. 2023 was NT$-43.75 Mil. Andros Pharmaceuticals Co's Revenue for the six months ended in Dec. 2023 was NT$0.34 Mil. Therefore, Andros Pharmaceuticals Co's net margin for the quarter that ended in Dec. 2023 was -12,754.52%.

The historical rank and industry rank for Andros Pharmaceuticals Co's Net Margin % or its related term are showing as below:

ROCO:6917' s Net Margin % Range Over the Past 10 Years
Min: -39418.37 Med: -2403.74 Max: -278.92
Current: -8466.96

ROCO:6917's Net Margin % is ranked worse than
89.58% of 1027 companies
in the Biotechnology industry
Industry Median: -151.78 vs ROCO:6917: -8466.96

Andros Pharmaceuticals Co Net Margin % Historical Data

The historical data trend for Andros Pharmaceuticals Co's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Andros Pharmaceuticals Co Net Margin % Chart

Andros Pharmaceuticals Co Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Net Margin %

-39,418.37

-1,098.13

-278.92

-2,403.74

-8,466.96

Andros Pharmaceuticals Co Semi-Annual Data
	Dec19	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Net Margin %	Get a 7-Day Free Trial			-840.56	-1,832.59	-3,279.88	-5,283.77	-12,754.52

Competitive Comparison of Andros Pharmaceuticals Co's Net Margin %

For the Biotechnology subindustry, Andros Pharmaceuticals Co's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Andros Pharmaceuticals Co's Net Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Andros Pharmaceuticals Co's Net Margin % distribution charts can be found below:

* The bar in red indicates where Andros Pharmaceuticals Co's Net Margin % falls into.

Andros Pharmaceuticals Co Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Andros Pharmaceuticals Co's Net Margin for the fiscal year that ended in Dec. 2023 is calculated as

Net Margin	=	Net Income (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	-68.159	/	0.805
	=	-8,466.96 %

Andros Pharmaceuticals Co's Net Margin for the quarter that ended in Dec. 2023 is calculated as

Net Margin	=	Net Income (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	-43.748	/	0.343
	=	-12,754.52 %

Andros Pharmaceuticals Co (ROCO:6917) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

Andros Pharmaceuticals Co Net Margin % Related Terms

Thank you for viewing the detailed overview of Andros Pharmaceuticals Co's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Andros Pharmaceuticals Co (ROCO:6917) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Andros Pharmaceuticals Co Ltd (ROCO:6917) » Definitions » Net Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 22, Sec. 2, Shengyi Road, 6th Floor, Building D, Biotech Building, Hsinchu Biomedical Science Park, Hsinchu County, Zhubei City, TWN, 30261

Website

http://www.androspharma.com

Andros Pharmaceuticals Co Ltd is a biopharmaceutical company engaged in developing novel drug delivery platform technologies. The firm focuses on the development of topical new dosage forms and non-viral gene delivery systems, with the current pipeline indicated for pain management, DNA repair, and gene therapy. Its product line comprises New Dosage Forms (Topical), Super Generics (Topical), High-End Cosmetic Ingredients (Topical), and Gene Delivery Systems (Injectable).

Andros Pharmaceuticals Co (ROCO:6917) Headlines

No Headlines